Abstract Temozolomide (TMZ) therapy offers minimal clinical benefits in patients with glioblastoma multiforme (GBM) with high EGFR activity. underscoring the need for effective combination therapy. Here. we show that tonicity-responsive enhancer binding protein (NFAT5) lysine methylation. https://www.bempresas.com/